- Home
- RAND vs LVTX Comparison
RAND vs LVTX Comparison
Compare RAND & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- LVTX
- Stock Information
- Founded
- RAND 1969
- LVTX 2016
- Country
- RAND United States
- LVTX Netherlands
- Employees
- RAND N/A
- LVTX N/A
- Industry
- RAND Finance: Consumer Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- RAND Finance
- LVTX Health Care
- Exchange
- RAND Nasdaq
- LVTX Nasdaq
- Market Cap
- RAND 47.5M
- LVTX 43.9M
- IPO Year
- RAND N/A
- LVTX 2021
- Fundamental
- Price
- RAND $17.13
- LVTX $1.65
- Analyst Decision
- RAND
- LVTX Strong Buy
- Analyst Count
- RAND 0
- LVTX 2
- Target Price
- RAND N/A
- LVTX $6.00
- AVG Volume (30 Days)
- RAND 2.1K
- LVTX 33.9K
- Earning Date
- RAND 11-04-2024
- LVTX 11-14-2024
- Dividend Yield
- RAND 6.77%
- LVTX N/A
- EPS Growth
- RAND 72.67
- LVTX N/A
- EPS
- RAND 4.19
- LVTX N/A
- Revenue
- RAND $7,874,601.00
- LVTX $7,398,000.00
- Revenue This Year
- RAND N/A
- LVTX N/A
- Revenue Next Year
- RAND N/A
- LVTX N/A
- P/E Ratio
- RAND $4.09
- LVTX N/A
- Revenue Growth
- RAND 13.24
- LVTX N/A
- 52 Week Low
- RAND $12.50
- LVTX $1.13
- 52 Week High
- RAND $19.60
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- RAND 52.43
- LVTX 46.15
- Support Level
- RAND $16.46
- LVTX $1.59
- Resistance Level
- RAND $17.26
- LVTX $1.75
- Average True Range (ATR)
- RAND 0.33
- LVTX 0.08
- MACD
- RAND 0.08
- LVTX 0.00
- Stochastic Oscillator
- RAND 86.87
- LVTX 41.18
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, diversified management company. The firm's investment objectives is to maximize the total return to the shareholders with current income combined with capital appreciation. Some of its portfolios include lumious, and GiveGab among others.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.